Maravai LifeSciences Files 2024 DEF 14A
Ticker: MRVI · Form: DEF 14A · Filed: Apr 18, 2025 · CIK: 1823239
| Field | Detail |
|---|---|
| Company | Maravai Lifesciences Holdings, Inc. (MRVI) |
| Form Type | DEF 14A |
| Filed Date | Apr 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, equity-awards
TL;DR
Maravai's 2024 proxy statement is out, detailing exec pay and equity awards.
AI Summary
Maravai LifeSciences Holdings, Inc. filed its DEF 14A on April 18, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity awards granted to individuals like Mr. Hull and Mr. Martin. It also provides financial data for the years 2020 through 2024, with specific figures for equity awards and their valuations.
Why It Matters
This filing provides crucial transparency into the compensation packages of Maravai's top executives, which can influence investor decisions and perceptions of the company's governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that primarily discloses executive compensation and related corporate governance information, with no immediate indication of significant new risks.
Key Numbers
- 2024 — Fiscal Year End (The filing covers the fiscal year ending December 31, 2024.)
- 2020-2024 — Reporting Period (Financial data and equity award information are presented for these years.)
Key Players & Entities
- MARAVAI LIFESCIENCES HOLDINGS, INC. (company) — Filer
- Mr. Hull (person) — Executive
- Mr. Martin (person) — Executive
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was this DEF 14A filing submitted?
This DEF 14A filing was submitted on April 18, 2025.
What is the fiscal year end for Maravai LifeSciences Holdings, Inc. as indicated in the filing?
The fiscal year end for Maravai LifeSciences Holdings, Inc. is December 31.
Does the filing mention specific executive names in relation to equity awards?
Yes, the filing references executive compensation details for individuals such as 'mrvi:Mr.HullMember' and 'mrvi:Mr.MartinMember'.
What is the SIC code for Maravai LifeSciences Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Maravai LifeSciences Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 18, 2025 by Mr. Hull regarding MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).